Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes [Phase 4]
A Phase 4 trial evaluated the combination of gliclazide MR with basal insulin versus insulin alone in type 2 diabetes, with completed status…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients [Phase 4]
Phase 4 trial update examining how hypoglycemic drugs affect testosterone levels in adults with Type 2 Diabetes.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin
Trial update for the active surveillance program assessing safety and effectiveness of linagliptin in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients [Phase 2]
Phase 2 immunogenicity study comparing insulin glargine Ezelin to Lantus in patients with type 2 diabetes mellitus completed.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Effects of Obesity Treatments on Food Preferences and Metabolism
A completed clinical trial from Imperial College London examining how obesity treatments influence food preferences and metabolism; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients [Phase 3]
Phase 3 trial investigating dapagliflozin plus exenatide in obese insulin-resistant patients with type 2 diabetes; study terminated.
-
FDA approval · 2020-03-30FDA Approved: JENTADUETO XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for JENTADUETO XR, a fixed-dose combination of linagliptin and metformin hydrochloride, manufactured…
-
FDA approval · 2020-03-30FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tradjenta (linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc., resulting in an upd…
-
FDA approval · 2020-03-30FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for JENTADUETO (linagliptin and metformin hydrochloride) from Boehringer Ingelheim, updating the pro…
-
FDA label_change · 2020-03-30FDA Approved: GLYXAMBI — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Glyxambi (empagliflozin and linagliptin), updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing LY900014 to insulin lispro in adults with Type 2 diabetes mellitus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial evaluating whether Exenatide LAR or Dulaglutide affect variability in 24-hour heart rate and blood pressure in adul…
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients [Phase 4]
A Phase 4 clinical trial evaluating the effects of dapagliflozin on heart work, heart nutrient uptake, and heart muscle efficiency in adults…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 Diabetes [NA]
Initial clinical evaluation of an endoscopic therapy for Type 2 diabetes has completed; results posted in 2020.
-
CLINICAL_TRIALS research · 2020-03-20Clinical Trial Update: Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation [NA]
A completed clinical trial evaluating abnormal blood sugar tests in diabetic patients undergoing colonoscopy prep.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD) [Phase 3]
A Phase 3 trial comparing fixed-ratio insulin degludec/liraglutide versus insulin degludec in combination with metformin in Chinese adults w…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial update evaluating basal insulin analog and insulin analog mid mixture in Chinese patients with type 2 diabetes mellitus comple…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial comparing cardiovascular effects of ticagrelor versus placebo in patients with type 2 diabetes mellitus has completed with r…
-
CLINICAL_TRIALS research · 2020-03-18Clinical Trial Update: A Psychological-behavioral Intervention for Physical Activity in Type 2 Diabetes [NA]
A completed clinical trial evaluating a psychological-behavioral intervention to improve physical activity in adults with type 2 diabetes.
-
FDA approval · 2020-03-16FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)
The FDA approved a supplemental application for colesevelam hydrochloride (Glenmark Pharmaceuticals Inc., USA), updating the product's label…
-
FDA approval · 2020-03-16FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for Colesevelam hydrochloride by Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Hypoglycemia (Low Blood Sugar) and the Heart [NA]
Completed clinical trial evaluating hypoglycemia in individuals with type 2 diabetes; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial update for TQ-F3083 capsules in adults with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing fast-acting insulin aspart to NovoRapid/NovoLog in people with type 2 diabetes has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs [Phase 3]
A Phase 3 trial comparing insulin degludec to insulin glargine 300 U/mL in adults with type 2 diabetes inadequately controlled on basal insu…